In the latest market close, Gilead Sciences (GILD) reached $92.38, with a +1.52% movement compared to the previous day. The stock lagged the S&P 500's daily gain of 1.83%. Meanwhile, the Dow gained 1.

Gilead Sciences (GILD) ended the recent trading session at $89.14, demonstrating a -1.64% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of ...

Therefore, the Zacks rating upgrade for Gilead basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in ...

Shares of Gilead Sciences Inc. GILD rallied 1.52% to $92.38 Wednesday, on what proved to be an all-around great trading ...

Right now, Gilead Sciences is sporting a Zacks Rank of #2 (Buy), while Vertex ... Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total ...

The Zacks Medical - Biomedical and Genetics industry, to which Gilead belongs, has lost 7.6% over this period. Now the key question is: Where could the stock be headed in the near term?

Gilead Sciences Inc (GILD) stock saw a decline, ending the day at $92.01 which represents a decrease of $-2.10 or -2.23% from the prior close of $94.11. The stock opened at $93.93 and touched a low of ...

Gilead Sciences Inc (GILD) stock saw a decline, ending the day at $94.11 which represents a decrease of $-0.30 or -0.32% from the prior close of $94.41. The stock opened at $93.43 and touched a low of ...

Shares of Gilead Sciences Inc. GILD inched 0.07% higher to $89.94 Monday, on what proved to be an all-around positive trading ...